LEO Pharma Research Foundation awards 2011
Ballerup, Denmark, 23 November 2011
The LEO Pharma Research Foundation’s Gold and Silver awards 2011 go to Claus Johansen and Charlotte Menné Bonefeld – young researchers with exceptional achievements in dermatology.
Gold award
The DKK 1,000,000 award goes to 38-year-old Danish dermatological researcher Claus Johansen. His research over the years has focused on the complex network of intra-cellular signals controlling inflammatory skin disorders, particularly in relation to psoriasis. The results have furthered understanding of the inflammatory process in psoriasis – key knowledge for the future development of new therapies.
Silver award
The 36-year-old immunologist Charlotte Menné Bonefeld receives the DKK 500,000 award for her research achievements in dermatology. Her research includes new promising results, which show that the immune system weakens – in other words develops tolerance – when someone is repeatedly exposed to strong allergens such as those found in hair dyes. The results offer new insight into treatment possibilities and the reasons why people develop allergies.
Contact
Corporate Communications Manager, LEO Pharma, Eva Juul Langlands: +45 4188 3094/+45 7226 2059, eva.langlands@leo-pharma.com.
About LEO Pharma Research Foundation
With its own board, the LEO Pharma Research Foundation is independent of both the LEO Foundation and LEO Pharma. The foundation itself selects candidates for the Gold and Silver awards.
About LEO Pharma
Founded in 1908, LEO Pharma is an independent, research-based pharmaceutical company. LEO Pharma develops, manufactures and markets pharmaceutical drugs to dermatologic and thrombotic patients in more than 100 countries globally. The company has its own sales forces in 59 countries and employs some 4,600 employees worldwide. LEO Pharma is headquartered in Denmark and is wholly owned by the LEO Foundation. For more information about LEO Pharma, visit www.leo-pharma.com.